Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Whitehouse Labs Increases Testing Resources | Contract Pharma
Breaking News

Whitehouse Labs Increases Testing Resources

Adds USP 661.1 and 661.2 Packaging Qualification

Whitehouse Laboratories, a division of AMRI, has increased its testing resources dedicated to U.S. Pharmacopeia (USP) Chapters 661.1 and 661.2 for packaging component qualification.

According to these USP chapters, all primary packaging components and some secondary packaging components must comply with the applicable standards, USP 661.1, 661.2, 660, 670, and/or 381. Whitehouse Labs is also testing several clients’ associated packaging components, such as spoons, dosing cups, and dosing syringes, for dosing accuracy, as well as per the relevant USP chapters.

While many companies have been qualifying their containers and container closure systems in accordance with the requirements of USP 661.1 and 661.2, the systems tested often omit some primary, secondary, and/or associated packaging components as defined in USP 659, such as desiccant canisters and sachets which come into direct contact with the packaged product. Depending on the risk and product category, testing considerations may include identification, infrared spectrophotometry, thermal analysis, extractables and leachables, plastic additives, physicochemical tests, metals, elemental analysis, bioburden, and biological reactivity.

“With an ever-expanding expert team and knowledge base, Whitehouse Laboratories is the premier source for container closure packaging system qualification,” said Amanda Wohlleber, general manager at Whitehouse Labs. “In order to keep up with the increased demand for testing services, we have added expertise and increased capacity in the applicable testing areas – including 661.1, 661.2, 381, 87, 88, 660, 670 – specifically regarding additional associated packaging components.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters